Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Meenhorst

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Therapeutic Drug Monitoring|December 1, 1994
Therapeutic drug monitoring of phenytoin in patients with the acquired immunodeficiency syndromeD M Burger, P L Meenhorst, J W Mulder, et al.
The Journal of Rheumatology|February 1, 1989
Polyarticular Salmonella bacterial arthritis in a patient with systemic lupus erythematosusM A van de Laar, P L Meenhorst, R M van Soesbergen, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 1, 1993
2',3'-dideoxyinosine (ddI): its chemical stability and cyclodextrin complexation in aqueous mediaO Bekers, J H Beijnen, M J Tank, et al.
AIDS (London, England)|December 1, 1993
Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIVD M Burger, C L Kraaijeveld, P L Meenhorst, et al.
Journal of Toxicology. Clinical Toxicology|December 29, 1998
Survival after massive ecstasy overdoseS Ramcharan, P L Meenhorst, J M Otten, et al.
The Netherlands Journal of Medicine|May 1, 1994
Short-term, combined use of paracetamol and zidovudine does not alter the pharmacokinetics of either drugD M Burger, P L Meenhorst, W J Underberg, et al.
Antiviral Therapy|March 7, 2002
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experienceR P van Heeswijk, A Veldkamp, J W Mulder, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patientsR M Hoetelmans, C L Kraaijeveld, P L Meenhorst, et al.
AIDS (London, England)|April 15, 1999
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.
Antiviral Therapy|July 1, 1997
Clinically relevant drug interactions with antiretroviral agentsD M Burger, R M Hoetelmans, P P Koopmans, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|December 1, 1994
Therapeutic drug monitoring of phenytoin in patients with the acquired immunodeficiency syndromeD M Burger, P L Meenhorst, J W Mulder, et al.
The Journal of Rheumatology|February 1, 1989
Polyarticular Salmonella bacterial arthritis in a patient with systemic lupus erythematosusM A van de Laar, P L Meenhorst, R M van Soesbergen, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 1, 1993
2',3'-dideoxyinosine (ddI): its chemical stability and cyclodextrin complexation in aqueous mediaO Bekers, J H Beijnen, M J Tank, et al.
AIDS (London, England)|December 1, 1993
Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIVD M Burger, C L Kraaijeveld, P L Meenhorst, et al.
Journal of Toxicology. Clinical Toxicology|December 29, 1998
Survival after massive ecstasy overdoseS Ramcharan, P L Meenhorst, J M Otten, et al.
The Netherlands Journal of Medicine|May 1, 1994
Short-term, combined use of paracetamol and zidovudine does not alter the pharmacokinetics of either drugD M Burger, P L Meenhorst, W J Underberg, et al.
Antiviral Therapy|March 7, 2002
Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experienceR P van Heeswijk, A Veldkamp, J W Mulder, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patientsR M Hoetelmans, C L Kraaijeveld, P L Meenhorst, et al.
AIDS (London, England)|April 15, 1999
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.
Antiviral Therapy|July 1, 1997
Clinically relevant drug interactions with antiretroviral agentsD M Burger, R M Hoetelmans, P P Koopmans, et al.
Pageof 10